| Autor: |
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Nur, Tozluklu, Emine, Bağir, Sedef, Kuran |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
European Journal of Gastroenterology & Hepatology. 35:89-93 |
| ISSN: |
0954-691X |
| DOI: |
10.1097/meg.0000000000002452 |
| Popis: |
Hepatocellular carcinoma (HCC) is the seventh most common cancer all worldwide and is second in cancer-related deaths. In HCC, whose prognosis is still not good despite current treatments, there is a need for prognostic markers as well as early diagnosis. Glypican (GPC)-3 has been proposed as a potential serologic and histochemical marker specific to HCC. This study aimed to determine the relationship between GPC3 overexpression and HCC prognosis and clinicomorphologic features.In total 152 patients who were diagnosed as a result of hepatectomy, lobectomy or liver transplantation were enrolled. The patients were divided into two groups, GPC3-positive (overexpression) (10%) and GPC3-negative (10%). The demographic data of the patients, tumor characteristics and survival times were recorded.Survival was significantly lower in the GPC3+ group. In the multivariate analysis, hepatitis C, AFP, tumor number, tumor focality, portal vein tumor thrombosis and GLP3 positivity were found to be independent risk factors for survival.Our study shows that GPC3 overexpression is a poor prognostic factor in HCC. GPC3 positivity were found to be an independent risk factor for survival. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
